awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q39062830-10B6C6C3-1F9F-4EE9-B33D-E07408F2D991
Q39062830-10B6C6C3-1F9F-4EE9-B33D-E07408F2D991
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39062830-10B6C6C3-1F9F-4EE9-B33D-E07408F2D991
New and Emerging Therapies and Targets: Beta-3 Agonists.
P2860
Q39062830-10B6C6C3-1F9F-4EE9-B33D-E07408F2D991
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39062830-10B6C6C3-1F9F-4EE9-B33D-E07408F2D991
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
44a7183b300fb394374c5e083e409f3a6ea58de3
P2860
Cardiac endothelium-myocyte interaction: clinical opportunities for new heart failure therapies regardless of ejection fraction